Skip to main content
Top
Published in: Familial Cancer 3-4/2003

01-09-2003

Abstracts presented at the Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer (ICG-FBOC) 14th General Meeting at the Centro Nacional de Investigaciones Oncológica (CNIO), Madrid, Spain, 2–4 June 2003 Abstracts/posters

Published in: Familial Cancer | Issue 3-4/2003

Login to get access
Metadata
Title
Abstracts presented at the Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer (ICG-FBOC) 14th General Meeting at the Centro Nacional de Investigaciones Oncológica (CNIO), Madrid, Spain, 2–4 June 2003 Abstracts/posters
Publication date
01-09-2003
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 3-4/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1023/B:FAME.0000004661.28258.f0

Other articles of this Issue 3-4/2003

Familial Cancer 3-4/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine